277 related articles for article (PubMed ID: 18638365)
1. Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins.
Liu L; Celma CC; Roy P
Virol J; 2008 Jul; 5():82. PubMed ID: 18638365
[TBL] [Abstract][Full Text] [Related]
2. N-Glycans on the Rift Valley Fever Virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGN.
Phoenix I; Nishiyama S; Lokugamage N; Hill TE; Huante MB; Slack OA; Carpio VH; Freiberg AN; Ikegami T
Viruses; 2016 May; 8(5):. PubMed ID: 27223297
[TBL] [Abstract][Full Text] [Related]
3. Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep.
Faburay B; Wilson W; McVey DS; Drolet BS; Weingartl H; Madden D; Young A; Ma W; Richt JA
Vector Borne Zoonotic Dis; 2013 Sep; 13(9):619-29. PubMed ID: 23962238
[TBL] [Abstract][Full Text] [Related]
4. Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses.
Habjan M; Penski N; Wagner V; Spiegel M; Overby AK; Kochs G; Huiskonen JT; Weber F
Virology; 2009 Mar; 385(2):400-8. PubMed ID: 19155037
[TBL] [Abstract][Full Text] [Related]
5. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
[TBL] [Abstract][Full Text] [Related]
6. Generation and application of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein NP and glycoproteins Gn and Gc.
Jäckel S; Eiden M; Dauber M; Balkema-Buschmann A; Brun A; Groschup MH
Arch Virol; 2014 Mar; 159(3):535-46. PubMed ID: 24100475
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the Molecular Interactions That Govern the Packaging of Viral RNA Segments into Rift Valley Fever Phlebovirus Particles.
Tercero B; Narayanan K; Terasaki K; Makino S
J Virol; 2021 Jun; 95(14):e0042921. PubMed ID: 33952635
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of Rift Valley fever virus-like particles.
Li YT; Wang CL; Zheng XX; Wang HL; Zhao YK; Gai WW; Jin HL; Gao YW; Li N; Yang ST; Xia XZ
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050999
[TBL] [Abstract][Full Text] [Related]
9. Characterization of baculovirus-expressed Rift Valley fever virus glycoproteins synthesized in insect cells.
Takehara K; Morikawa S; Bishop DH
Virus Res; 1990 Nov; 17(3):173-90. PubMed ID: 2077783
[TBL] [Abstract][Full Text] [Related]
10. Expression of Rift Valley fever virus N-protein in Nicotiana benthamiana for use as a diagnostic antigen.
Mbewana S; Meyers AE; Weber B; Mareledwane V; Ferreira ML; Majiwa PAO; Rybicki EP
BMC Biotechnol; 2018 Dec; 18(1):77. PubMed ID: 30537953
[TBL] [Abstract][Full Text] [Related]
11. An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep.
Said A; Elmanzalawy M; Ma G; Damiani AM; Osterrieder N
Virol J; 2017 Aug; 14(1):154. PubMed ID: 28807043
[TBL] [Abstract][Full Text] [Related]
12. Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression.
Phoenix I; Lokugamage N; Nishiyama S; Ikegami T
Viruses; 2016 May; 8(6):. PubMed ID: 27231931
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Fluorescence Microsphere Immunoassay for Detection of Antibodies to Rift Valley Fever Virus Nucleocapsid Protein and Glycoproteins.
Ragan IK; Davis AS; McVey DS; Richt JA; Rowland RR; Wilson WC
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563201
[TBL] [Abstract][Full Text] [Related]
14. Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus.
Pichlmair A; Habjan M; Unger H; Weber F
Vector Borne Zoonotic Dis; 2010 Oct; 10(7):701-3. PubMed ID: 20854024
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an Indirect Enzyme-Linked Immunosorbent Assay Based on Recombinant Baculovirus-Expressed Rift Valley Fever Virus Nucleoprotein as the Diagnostic Antigen.
Faburay B; Wilson WC; Secka A; Drolet B; McVey DS; Richt JA
J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31366690
[TBL] [Abstract][Full Text] [Related]
16. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins.
Latham T; Galarza JM
J Virol; 2001 Jul; 75(13):6154-65. PubMed ID: 11390617
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus.
Näslund J; Lagerqvist N; Habjan M; Lundkvist A; Evander M; Ahlm C; Weber F; Bucht G
Virology; 2009 Mar; 385(2):409-15. PubMed ID: 19157482
[TBL] [Abstract][Full Text] [Related]
18. Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge.
de Boer SM; Kortekaas J; Antonis AF; Kant J; van Oploo JL; Rottier PJ; Moormann RJ; Bosch BJ
Vaccine; 2010 Mar; 28(11):2330-9. PubMed ID: 20056185
[TBL] [Abstract][Full Text] [Related]
19. Equine immunoglobulin F(ab')
Zhao Y; Zheng X; He S; Li Y; Wang W; Gai W; Wong G; Wang H; Yan F; Xue F; Feng N; Wang T; Gao Y; Yang S; Qiu X; Xia X
Int Immunopharmacol; 2018 Nov; 64():217-222. PubMed ID: 30199846
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic insight into the efficient packaging of antigenomic S RNA into Rift Valley fever virus particles.
Tercero B; Terasaki K; Narayanan K; Makino S
Front Cell Infect Microbiol; 2023; 13():1132757. PubMed ID: 36875526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
